|1.||Buus, Søren: 2 articles (05/2014 - 11/2011)|
|2.||Stryhn, Anette: 2 articles (05/2014 - 11/2011)|
|3.||Harndahl, Mikkel: 2 articles (05/2014 - 11/2011)|
|4.||Matthews, Philippa C: 1 article (05/2014)|
|5.||Brander, Christian: 1 article (05/2014)|
|6.||Goulder, Philip: 1 article (05/2014)|
|7.||Takiguchi, Masafumi: 1 article (05/2014)|
|8.||Shapiro, Roger: 1 article (05/2014)|
|9.||Kløverpris, Henrik N: 1 article (05/2014)|
|10.||Walker, Bruce D: 1 article (05/2014)|
04/01/2014 - "Variation in LD between the classic HLA loci, rs9272143 and rs67841474 between populations may explain the different associations of HLA-B*07 and DRB1*1501-DQB1*0602 with cervical cancer between studies. "
01/01/2011 - "HLA-B*07 is a high risk allele for cervical cancer, and has strong potential for use as a molecular biomarker."
01/01/2011 - "We found several high risk alleles in women with familial cervical cancer, that associated with the highest risk being HLA-B*07 (OR = 8.7, 95% CI = 1.8-41.1). "
01/01/2011 - "HLA-B*07 is a high risk allele for familial cervical cancer."
04/01/2014 - "The association of classic human leukocyte antigen (HLA) alleles with risk of cervical cancer has been extensively studied, and a protective effect has consistently been found for DRB1*1301, DQA1*0103, and/or DQB1*0603 (these three alleles are in perfect linkage disequilibrium [LD] and often occur on the same haplotype in Europeans), while reports have differed widely with respect to the effect of HLA-B*07, DRB1*1501, and/or DQB1*0602 (the last two alleles are also in perfect LD in Europeans). "
05/01/2014 - "This study investigates the observation that HLA-B*07:02 is not associated with a high viral setpoint in C-clade infection. "
05/01/2014 - "Although this epitope was also targeted in B-clade infection, the escape mutant S357S is present at higher frequency in B-clade infection than in C-clade infection (70% versus 43% in HLA-B*07:02-negative subjects). "
05/01/2014 - "In particular, a novel p17-Gag (Gag22-30, RPGGKKHYM) epitope is targeted in >50% of HLA-B*07:02-positive C-clade-infected individuals but clade-specific differences in this epitope result in nonimmunogenicity in B-clade infection. "
10/01/2007 - "HLA-B*07 was observed to be significantly associated with HPV16/18 infection in asymptomatic controls (OR(age-adjusted) = 4.73; 95% CI: 1.55-14.45; P = 0.006) and CaCx (OR(age-adjusted) = 6.14; 95% CI: 2.15-17.53; P < 0.001) in this enhanced sample set of CaCx cases. "
05/01/2014 - "HLA-B*07:02 is an HLA class I molecule that is prevalent in most populations worldwide and that has previously been consistently linked to accelerated disease progression in B-clade infection. "
|3.||Alzheimer Disease (Alzheimer's Disease)
09/01/2009 - "Following the replication of the association of the human leucocyte antigen (HLA) allele, HLA-B*07, with Alzheimer's disease (AD) in the cohort of the Oxford Project to Investigate Memory and Ageing (OPTIMA) in a previous study, we examined whether that association could be due to linkage disequilibrium with MICA or MICB alleles. "
04/01/2009 - "In the TSG, DR*B11 (odds ratio [OR], 0.48; 95% confidence interval [CI], 0.26-0.90; P=0.02) was significantly associated with lack of trichiasis, whereas HLA-B*07 (OR, 3.26; 95% CI, 1.42-7.49; P=0.004) and HLA-B*08 (OR, 5.12; 95% CI, 1.74-15.05; P=0.001) were associated with trichiasis. "
|5.||Genetic Predisposition to Disease (Genetic Predisposition)
|2.||HLA-DQB1 antigen (HLA DQB1)
|5.||HLA-B Antigens (HLA-B)
|6.||HLA-A Antigens (HLA-A)
|7.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)